Please see my reply to your second post; I didn't notice this one until just now.
Hope I am not too late in replying but re survival rates they seem so reluctant to tell us anything. I had a second opinion and for my specific situation which is similar but not identical to you I was told the following.
I just turned 41, was dx triple neg in May 09, grade 3, stage 3, had a lumpectomy (3cm lump) followed by a re-excision and removal of infected lymph nodes 17/17. Also told I had significant vascular invasion plus extracapsular....
Specialist said there is a very high likelihood of recurrence approx 80%, also asked the survival rate he said 30-40% chance of surviving 5 years. If no recurrence within 5 years then I understand the chance of surviving a lot longer go up drastically. I also heard that in most cases triple neg comes back earlier rather than later so most likely in under 5 years if it is going to.
Try not to be too upset, I figure we normally never know what the future holds at least this way you have a chance to make sure you live the next few years properly but with an eye to surviving for a lot longer ( positive thinking seems to work, you rarely see a negative thinking survivor, its hard but do-able others have had worse prognoses and survived). I met a lady recently who was given 3 months to live and fought it, that was 3 years ago.
PARP Inhibitors: The Next Great Breast Cancer Treatment?
Over the past few months, you may have heard about PARP inhibitors, a new family of medicines that dominated headlines from the June annual meeting of the American Society of Clinical Oncology. The medications, which target the way cancer cells repair themselves, could revolutionize treatment for breast and other cancers, doctors say. But what do these developments mean for you? And when will they be available?
While the findings are exciting, we still have a lot to learn. The early studies,suggest PARP inhibitors could work powerfully against some types of metastatic triple-negative and hereditary breast cancers. The findings were so impressive that the New England Journal of Medicine took the unusual step of calling for FDA approval of a PARP inhibitor based on results of a Phase I clinical trial, only the first of three steps normally needed for approval.
If you are triple negative please check this out thoroughly. PARP inhibitor's... ask your doctor about trials going on and if you can get it, VERY PROMISING.
Here is a good place to start your research: http://www.facingourrisk.org/newsletter/2009fall/parp_inhibitor_research.html
Read more here: